Selected Bibliography

The following list is a selected bibiograpy of texts that inform my clinical practice.
I intend to add hyperlinks to the open material and links to amazon for the books in copyright
Balick, M. J., Weil, A., Mattern, V., & Low Dog, T. (2014). Rodale’s 21st-century herbal: a practical guide for healthy living using nature’s most powerful plants. New York, NY: Rodale.
Balles, T. (2004). Dancing with the ten thousand things: ways to become a powerful healing presence. New York; Lincoln, Neb.: iUniverse, Inc.
Blumenthal, M., Busse, W. R., & Bundesinstitut für Arzneimittel und Medizinprodukte (Germany) (Eds.). (1998). The complete German Commission E monographs, Therapeutic guide to herbal medicines. Austin, Texas : Boston: American Botanical Council ; Integrative Medicine Communications.
Bone, K. (1996). Clinical applications of Ayurvedic and Chinese herbs: monographs for the Western herbal practitioner. Warwick, Qld.: Phytotherapy Press.
Bone, K. (2003). A clinical guide to blending liquid herbs: herbal formulations for the individual patient. St. Louis, Mo: Churchill Livingstone.
Bone, K., & Mills, S. (2013). Principles and practice of phytotherapy: modern herbal medicine (2nd ed). Edinburgh: Churchill Livingstone, Elsevier.
Braun, L., & Cohen, M. (2010). Herbs & natural supplements: an evidence-based guide (3rd ed.). Sydney; New York.: Elsevier Australia.
Braun, L., & Cohen, M. (2015a). Herbs and natural supplements an evidence-based guide. (4th ed., Vol. 2). Edinburgh: Churchill Livingstone.
Braun, L., & Cohen, M. (2015b). Herbs and natural supplements an evidence-based guide. (4th ed., Vol. 1). Edinburgh: Churchill Livingstone.
British Herbal Medicine Association (Ed.). (1983). British Herbal Pharmacopoeia. Bournemouth: British Herbal Medicine Association.
Chevallier, A. (1996). The encyclopedia of medicinal plants (1st American ed). New York : Boston: DK Pub. ; Distributed by Houghton Mifflin.
Conway, P. (2011a). Phytotherapy in context. In The Consultation in Phytotherapy (pp. 1–38). Elsevier. Retrieved from
Conway, P. (2011b). The consultation in phytotherapy: the herbal practitioner’s approach to the patient, diagnosis, and treatment. Edinburgh ; New York: Churchill Livingstone Elsevier.
Duke, J. A. (2016). Dr. Duke’s Phytochemical and Ethnobotanical Databases. Ag Data Commons. Retrieved from
Easley, T., & Horne, S. H. (2016). The modern herbal dispensatory: a medicine-making guide. Berkeley, California: North Atlantic Books.
Essential Science Publishing. (2000). Essential oils: desk reference. Place of publication not identified: Essential Science Pub.
European Scientific Cooperative on Phytotherapy (Ed.). (2003). ESCOP monographs. [Hauptbd.]: […] (2. ed., completely rev. and expanded). Exeter: ESCOP [u.a.].
Felter, H., & Lloyd, J. U. (1898). King’s American Dispensatory, 1898. | Henriette’s Herbal Homepage. Retrieved July 7, 2016, from
Foster, S., & Duke, J. (2014). Peterson Field Guide to Medicinal Plants and Herbs of Eastern and Central North America. (3rd ed.). New York, NY: Houghton Mifflin Harcourt.
Ganora, L. (2009). Herbal constituents: foundations of phytochemistry : a holistic approach for students and practitioners of botanical medicine. Louisville, Colo.: Herbalchem Press.
Gardner, Z. E., McGuffin, M., & American Herbal Products Association (Eds.). (2013). American Herbal Products Association’s botanical safety handbook (2nd ed). Boca Raton: American Herbal Products Association, CRC Press.
Green, J. (2000). The herbal medicine-makers’ handbook: a home manual. Freedom, Calif: The Crossing Press.
Grieve, M. (1971). A modern herbal; the medicinal, culinary, cosmetic and economic properties, cultivation and folk-lore of herbs, grasses, fungi, shrubs, & trees with all their modern scientific uses. New York: Dover Publications.
Hardin, J. (2014). Traditions in Western Herbalism Essays And Class Notes: Essential Information & Skills. (K. Rose, Ed.). CreateSpace Independent Publishing Platform.
Hicks, A., Hicks, J., & Mole, P. (2011). Five element constitutional acupuncture (2nd ed). Edinburgh ; New York: Churchill Livingstone.
Hoffmann, D. (2003). Medical herbalism: the science and practice of herbal medicine. Rochester, Vt: Healing Arts Press.
Kennedy, D. O. (2014). Plants and the human brain. New York: Oxford University Press.
Marieb, E. N. (2015). Essentials of human anatomy & physiology (Eleventh edition). Boston: Pearson.
Moore, M. (2011). Medicinal plants of the Pacific West. Santa Fe: Museum of New Mexico Press.
Moore, M. (n.d.). PRINCIPLES AND PRACTICE OF CONSTITUTIONAL PHYSlOLOGY FOR HERBALISTS. Southwest School of Botanical Medicine. Retrieved from
Newcomb, L. (1977). Newcomb’s Wildflower Guide (1st ed.). New York, NY: Little Brown.
Pengelly, A. (2004). Constituents of medicinal plants: an introduction to the chemistry and therapeutics of herbal medicine (2nd ed). Wallingford, Oxon, OX ; Cambridge, MA: CABI Pub.
Skenderi, G. (2003). Herbal vade mecum: 800 herbs, spices, essential oils, lipids, etc., constituents, properties, uses, and caution. Rutherford, N.J: Herbacy Press.
Tilford, G. L., & Gladstar, R. (1998). From earth to herbalist: an earth-conscious guide to medicinal plants. Missoula, Mont: Mountain Press Pub. Co.
United Nations Industrial Development Organization, Handa, S. S., Khanuja, S. P. S., Longo, G., Rakesh, D. D., United Nations Industrial Development Organization, & International Centre for Science and High Technology. (2008). Extraction technologies for medicinal and aromatic plants. Trieste (Italy): Earth, Environmental and Marine Sciences and Technologies.
Van der Zee, B. (1982). Green pharmacy: a history of herbal medicine. New York: Viking Press.
VanMeter, K., Hubert, R. J., & Gould, B. E. (2014). Gould’s pathophysiology for the health professions.
Williamson, E. M. (2003). Potter’s herbal cyclopedia: the most modern and practical book for all those interested in the scientific as well as the traditional use of herbs in medicine. Saffron Walden: C.W. Daniel.
Williamson, E. M., Driver, S., & Baxter, K. (Eds.). (2009). Stockley’s herbal medicines interactions: a guide to the interactions of herbal medicines, dietary supplements and nutraceuticals with conventional medicines ([). London ; Chicago: Pharmaceutical Press.
Wood, M., & Ryan, D. (2016). The earthwise herbal repertory: the definitive practitioner’s guide. Berkeley, California: North Atlantic Books.

Energetics and pharmacology of sour plant acids


In the traditional energetic model of western herbal medicine (WHM) one way of conceptualizing energetics is to view them through the lenses of three distinct axes.   One lens is energy production which conventionally covers a gradient from cold, cooling, neutral, to warming, hot etc.  Another lens is tissue density, which ranges from moistening, through balancing, to drying.  A final lens involves tone which comprises concepts such as lax, tense, constricting, relaxing, and nourishing among others (Easley & Horne, 2016; McDonald, 2017).   

An intuitive understanding of energetics still exists at the heart of modern allopathic biomedicine where increasingly sophisticated diagnoses are paired with interventions designed to create increasingly sophisticated opposite effects. This awareness of opposites has been grounded in the logic of energetics since the time of Galen of Pergamum.  Despite the perceived imprecision that modern reductionist perspectives attribute to energetics, they remain a profound a diagnostic method in most traditional and integrative modalities (East Asian Medical Studies Society, 1985; McDonald, 2017).

Varying traditional energetic models differ somewhat in how they address sour botanicals.  In Western herbal medicine (WHM), plant medicines are typically considered cooling, drying, and nourishing (Easley & Horne, 2016).  In Traditional Chinese Medicine (TCM) the five element school considers sour botanicals to be moistening and softening whereas the taste/action school views sour plants as primarily astringent and fluid retaining (Kastner, 2009).

Ultimately, this paper proposes that the energetics attributed to sour plants represent a way to understand the pharmacologic actions provided by the constituents of those botanicals.  This method of understanding can be applied to acidic and astringent constituents biosynthesized at distinct and increasingly complex layers of the shikimic acid metabolic pathway.   Furthermore, the presence of lower pH constituents that trigger sour taste can provide insight into the therapeutic utility of sour plants even if the sour constituents are not the most therapeutically important constituents associated with the plants, as in the case of Schisandra chinensis (Turcz.) Baill.

Molecular perspective on Sour Taste

Our increasingly granular understanding of sour taste transduction (STT) remains imperfect.  While a complete picture of the intracellular response involved in sour taste is still hazy, the current consensus is that STT is mediated through potassium ion (k+) channels.  Specifically, nonselective cation transient receptor potential channels in the polycystic disease family PKD2L1 (a.k.a. TRPP3) and PKD1L3 (a.k.a TRPP1) (Ishimaru et al., 2006). The genes for these polycystins have been identified in both mouse and human genomes (Li, Tian, Sung, & Somlo, 2003).  When the PKD2L1 cells are selectively ablated in animal models, acid induced nerve responses are nearly eliminated (Chandrashekar et al., 2009).

Intracellular acidification also plays a role in the sour taste response. Weak acids can elicit a stronger sour response by diffusing along the lipid bilayer where stronger acids with the same pH are unable to diffuse across the cell membrane.  Ye et. al. explored the differing theories for how cytosolic acidification could impact action potentials in sour taste cells and demonstrated that sour taste cells are excited by the direct blocking of resting k+ currents in PKD2L1 cells (Ye et al., 2016).

The presence of the inward-rectifier k+ channel (KIR2.1) in PKD21L cells was identified as initiator of the pH sensitive k+ conductance up to a point.  KIR2.1 receptors are also present on non-sour taste receptors cells.  The higher density of KIR2.1 on the cell surface of non-sour taste receptors such as TRPM5 creates an insensitivity to intracellular acidification and greatly increases the number of channels that need to be closed to reach the action potential needed for the cell to fire.  So it is not just the interaction of intracellular pH on PKD21L, but also the lower magnitude of k+ current that triggers the sour response. Ye et. al. also demonstrate that in the presence of increased intracellular pH, zinc ion (Zn2+) proton conductance is displayed in PKD21L cells but not in TRPM5 cells.  This leads to the K+ current being blocked in sour taste cells exclusively (Ye et al., 2016).   This coupling of intracellular pH with inhibition of KIR2.1 provides insight into why weak acids are more sour than strong acids at similar ph.

Sour and astringent tastes are frequently conflated and occur simultaneously in a number of sour plants, despite relying on a taste mechanism other than STT, many astringent herbs are frequently classified energetically as cooling and drying with a sour taste such as Camellia sinensis(L.) Kuntze and Hamamelis virginiana L. (Easley & Horne, 2016). From a molecular perspective the sensation of astringency has been shown, unlike sour, to be a combination of the chemosensory and mechanosensory function of the trigeminal (TG) nerve perception of astringent phenols via G Protien-Coupled (GPRC) receptors and mechanical stimulation.  This conclusion was corroborated by results of both in-vitro and in-vivo experiments with plant phenols such as epigallocatechin gallate (EGCG) (Schöbel et al., 2014).    EGCO comprises as much as 25% of dried C. sinensis (Grigoras & Purdel, 2013).

Biosynthesis of phenolic sour and astringent constituents

Sour and astringent plant phenolics are biosynthesized along many increasingly complex points along the shikimic acid metabolic pathway with some exceptions using the acetate and malonate pathways.   This shikimic pathway is not present in Animalia, but many of the acids produced on the shikimate pathway are necessary components in animal metabolism.   This need for exogenous essential acids is one narrative for the convergent evolution of sour taste.

Shikimate biosynthesis gives rise to the citric, phenolic and fatty acids.  These acids share the presence of a carbonyl group (-CO) and a hydroxyl group (-OH).  When these functional groups bond they form a new functional group known collectively as the carboxyl (-COOH) acid group.  Carboxyl groups readily esterify with other hydroxyl groups.  The lower molecular carboxylic acids are also known as “weak” acids in that they are generally less acidic than the mineral acids.  They readily form hydrogen bonds and are therefore highly polar and water soluble.  This solubility leads to high bioavailability in water extractions (Ganora, 2009).  Many of the astringent tannins are further synthesized by reactions involving gallic acid whereas as higher molecular weight sour phenols are synthesized involving reactions involving cinnamic acid (Kennedy, 2014).     

The inclusion of a carboxyl group both in precursor metabolites as well as higher molecular weight phenolic constituents ensures that both low and high molecular weight phenolic compounds are often present in many therapeutic botanicals.  The presence of the arguably simpler carboxyl acids makes them prime candidates for being able to initiate STT by inhibiting both KIR2 and k+ ion receptors on PKD2L1 and PKD1L3 cells.  Similarly, many botanicals with complex phenolic therapeutic constituents such as hydrolyzable or condensed tannins also contain significant amounts of constituents which will trigger either STT or the sensation of astringency.

Chlorogenic Acids

One group of phenolic acids produced early in the shikimic pathway are the chlorogenic acids (CA).  A representative of this group is 3-O-caffeoylquinic acid (3CQA).  It is present in many notably sour plants such as Coffee arabicia L., Camellia sinensis(L.) Kuntze, Cratageus spp., and many of the Vaccinium such as V. macrocarpon Aiton and V. corymbosum L.  Clinical trials of this constituent lend credence to the traditional energetic claims that sour plants can be cooling and drying and relaxing to tissue.

One controlled clinical trial explored the effects of CA on nitric oxide (NO), endothelial function via flow mediated dilation (FMD) and blood pressure in healthy human subjects.  The researchers found a significant reduction in systolic blood pressure (SBP) (−2.41 mmHg, 95% CI: −0.03, −4.78; P = 0.05) as well as diastolic (DBP): (−1.53 mmHg, 95% CI: −0.05, −3.01; P = 0.04).  They did not observe a significant change in FMD or NO levels (Mubarak et al., 2012).   A more recent clinical trial with a wider range of CAs included did observe a higher FMD (p = 0.151), as well as reductions in SBP (p = 0.684) and DBP (p = 0.835) (Ochiai, Sugiura, Otsuka, Katsuragi, & Hashiguchi, 2015).   A third clinical study exploring the effects of CA from green coffee extract found significant reductions in blood pressure (SBP p <0.001, DBP p<0.05) in the intervention group, these researchers propose the possible mechanism may be NO mediated vasodilation (Watanabe et al., 2006).

An inflammatory state with many discrete inputs is implicated in the pathogenesis of liver fibrosis.   Hepatic cell lysis leads to an initial cytokine release which triggers Kupffer cells to release even more cytokines.  Newly activated hepatic state cells also release cytokines as they produce extracellular matrix in response to injury.   Lipopolysaccharides from gram negative bacteria also sensitize liver endothelial cells to produce cytokines.  While gold standard human studies of the effect of CA on inflammation are largely absent from the literature, there are a number of promising in-vitro studies.  CA was found to decrease the degree of hepatic fibrogenesis in-vitro.  It was also found to inhibit the activation of hepatic state cells and decrease the expression of toll-like receptors, nitric oxide synthase and COX-2 and serum levels of tumor necrosis factor, and interleukins 6 and 1B in cell matrixes treated with carbon tetrachloride (Shi et al., 2013).  The effects of CA on hepatic ischemia and reperfusion (H-I/R) was also explored by another team of researchers in-vitro.  Using an animal model CA was found to significantly attenuate serum alanine aminotransferase levels, portal inflammation, hepatocyte necrosis, hepatic lipid peroxidation and inflammatory cytokine levels at doses of 10 mg/kg (2840.4±688.8 U/L, P<.01).   Histologic results produced suggest that CA is a potent inhibitor of the pro-inflammatory protein high mobility group box 1 (HMGB1), TLR, Nuclear Factor Kappa B, and Interferon regulatory factor 1 all of which are significant contributors to the pathophysiology of H-I/R (Yun, Kang, & Lee, 2012).

The cooling, nourishing, and softening effects of CA on human endothelial cells and the promising in-vitro studies pursuant to the liver inflammation argues for the inclusion of botanicals rich in CA when addressing imbalances that give rise to tension and heat in the cardiovascular and hepatic systems.

Epigallocatechin gallate (EGCG)

Oligomeric proanthocyanidins are a class of condensed tannins that form an important group of constituents present in sour botanicals.  They are high molecular weight compounds capable of crosslinking with, and ultimately precipitating, proteins.   The flavan-3-ol EGCG is a catechin of this class that is present in large amounts in Camellia sinensis(L.) Kuntze a notable astringent botanical (Ganora, 2009).  There are an increasing number of human trials exploring the therapeutic effects of EGCG.

One recent study explored the effects of green tea on women with inflammatory lesions associated with acne vulgaris.  Patients in the intervention group were given an extract standardized to 856mg of EGCO and assessed after 4 weeks.  The researchers found a significant reduction in the number of inflammatory lesions (p = 0.46) leading to a lower score on the Cardiff Acne Disability Index (p = 0.28). The researchers also observed significant reductions in total cholesterol levels within the GTE group (Lu & Hsu, 2016).  Another phase II clinical trial explored the efficacy of a topical preparation of EGCG (AverTeaX, Camellix) in reducing the duration and severity of Herpes labialis.  The researchers observed a 50% reduction in episode duration in the intervention group (p=.0016).  They posit the mechanism is a result of EGCG directly binding to lipid membrane proteins (Zhao et al., 2015).    The effect of EGCG on interstitial cystitis has also been explored clinically.  A study published in the Journal of Surgical Research explored the effects of EGCG supplementation in-vivo as well as on cultured cell samples from the same test subjects.  The intervention group experienced significant reductions in total scores on an analog scale cystitis severity assessment tool.  The researchers also explored the effects of EGCG in-vitro on inflammatory markers and observed increased expression of purinergic X receptors and Y receptors in bladder urothelial cells derived from the IC patients.  They also recorded reduced expression of inflammatory markers iNOS, phosphorylated Akt, and NF-kB (Liu et al., 2013).  EGCG has also been studied as a possible intervention in ulcerative colitis.  After 56 days of therapy, 66.7% of the intervention group displayed improved scores on the Mean UC Disease Activity Index (p = 0.03) (Dryden, Lam, Beatty, Qazzaz, & McClain, 2013).

Ultimately, further research is needed.  While these studies involved small populations, and comprised results from both human and cellular models, they do contribute to the mounting evidence that phenolic tannins from a plant that is considered sour and astringent can serve therapeutically by providing pharmacological effects that manifest in cooling and drying actions on both internal and external inflammatory imbalances.  While not covered in this paper, other clinically important sour botanicals that are high in tannins that are considered cooling and drying include Arctostaphylos uva-ursi (L.) Spreng, Hamamelis virginiana L., Paeonia lactiflora Pall, and Quercus alba L. (Skenderi, 2003).


Lignans form another class of phenolic compounds comprised of phenlpropanoid derived hydroxycinnamyl alcohols.  Some therapeutically important lignans exist exclusively in sour plants, such as Schisandra chinensis (Turcz.) Baill.   While considered to encompass all five flavors, S. Chinensis fruit contains a large number of sour phenolics that trigger STT such as malic, tartaric, nigranoic citric, acidargolic and other carboxylic acids.  Schisandra also contains the higher molecular weight lignans schisandrin, schisandrins A-C, schizabdrols, schisantherins and gomasin A.

An exhaustive review of S. Cinensis was conducted by Panossian & Wikman in the Journal of Ethnopharmacology.  In the review, they outline much of the previous Soviet and post-Soviet era in-vivo research. They summarize evidence that schisandra increases endurance, provides a local anti-inflammatory effect, modulates gastric hypersecretion, as well as reducing the severity of gastric and duodenal ulcers (Panossian & Wikman, 2008).  A more recent review discussed results that provide convergent in-vitro evidence that schisandra lignans are also effective vasorelaxants by activating eNOS activity in endothelial cells, as well as exhibition anti-inflammatory characteristics by inhibiting a number of pro-inflammatory cytokines in myocardial tissues (Chun, Cho, So, & Jeon, 2014).  Similar in-vitro evidence of the anti-inflammatory effects on the hepatic respiratory and neurological system are covered in another recent review (Szopa, Ekiert, & Ekiert, 2017).  Schisandra has also been shown to improve liver function in healthy patients as well as patients with Hepatitis-C (Chiu, Chen, Tzeng, & Wang, 2013; Melhem et al., 2005)   Despite its comparatively recent entry into the WHM materia medica schisandra occupies a clinically important niche. From an energetic standpoint, schisandra exhibits cooling and nourishing properties towards inflamed tissue in many disparate organ systems such as the hepatic, cardiovascular and respiratory systems.


Plant energetic classifications are both elegant and messy.  Therapeutic plants are complex and traditional energetics represents one of the earlier methods of organizing them in a useful manner. Energetic classifications derive largely from the intimate experience and hard work of practitioners who worked with botanicals in a therapeutic context over the last two millennia.   Our increasingly granular understanding of receptor based pharmacology continues to deepen our understanding, and in many cases, these new insights serves to confirm the wisdom of the earlier energetic classifications.

Hopefully, this paper clarifies the link between acidic and astringent plant metabolites of varying molecular weights and the energetic qualities ascribed to them in traditional literature.  This paper also serves as an exposition of one method for approaching therapeutic botanicals based on constituent profile.  “Working backwards” to energetics from a chemical and pharmacological perspective grounded in the constituent’s biosynthetic pathway.  Integrating this modern perspective affords a practitioner the ability to develop a richer understanding of the mechanisms underlying traditional energetics and ultimately inform a more thorough clinical perspective that integrates well with modern biomedicine, to the benefit of the client/patient.


Challis, R. C., & Ma, M. (2016). Sour taste finds closure in a potassium channel. Proceedings of the National Academy of Sciences, 113(2), 246–247.

Chandrashekar, J., Yarmolinsky, D., Buchholtz, L. von, Oka, Y., Sly, W., Ryba, N. J. P., & Zuker, C. S. (2009). The Taste of Carbonation. Science, 326(5951), 443–445.

Chen, X., Huang, Y., Feng, J., Jiang, X.-F., Xiao, W.-F., & Chen, X.-X. (2014). Antioxidant and anti-inflammatory effects of Schisandra and Paeonia extracts in the treatment of asthma. Experimental and Therapeutic Medicine, 8(5), 1479–1483.

Chiu, H.-F., Chen, T.-Y., Tzeng, Y.-T., & Wang, C.-K. (2013). Improvement of liver function in humans using a mixture of schisandra fruit extract and sesamin. Phytotherapy Research: PTR, 27(3), 368–373.

Chun, J. N., Cho, M., So, I., & Jeon, J.-H. (2014). The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms. Fitoterapia, 97, 224–233.

Da-Costa-Rocha, I., Bonnlaender, B., Sievers, H., Pischel, I., & Heinrich, M. (2014). Hibiscus sabdariffa L. – A phytochemical and pharmacological review. Food Chemistry, 165, 424–443.

Ding, Y., Cao, Z., Cao, L., Ding, G., Wang, Z., & Xiao, W. (2017). Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase. Scientific Reports, 7.

Dryden, G. W., Lam, A., Beatty, K., Qazzaz, H. H., & McClain, C. J. (2013). A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis. Inflammatory Bowel Diseases, 19(9), 1904–1912.

Easley, T., & Horne, S. H. (2016). The modern herbal dispensatory: a medicine-making guide. Berkeley, California: North Atlantic Books.

East Asian Medical Studies Society (Ed.). (1985). Fundamentals of Chinese medicine. Brookline, Mass: Paradigm Publications.

Ganora, L. (2009). Herbal constituents: foundations of phytochemistry: a holistic approach for students and practitioners of botanical medicine. Louisville, Colo.: Herbalchem Press.

Grigoras, N., & Purdel, C. (2013, November 12). Assessment report on Camellia sinensis (L.) Kuntze, non fermentatum folium. European Medicines Agency. Retrieved from

Heitman, E., & Ingram, D. K. (2017). Cognitive and neuroprotective effects of chlorogenic acid. Nutritional Neuroscience, 20(1), 32–39.

Huyke, C., Engel, K., Simon-Haarhaus, B., Quirin, K.-W., & Schempp, C. M. (2007). Composition and Biological Activity of Different Extracts from Schisandra sphenanthera and Schisandra chinensis. Planta Medica, 73(10), 1116–1126.

Ishimaru, Y., Inada, H., Kubota, M., Zhuang, H., Tominaga, M., & Matsunami, H. (2006). Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. Proceedings of the National Academy of Sciences of the United States of America, 103(33), 12569–12574.

Kastner, J. (2009). Chinese nutrition therapy: dietetics in traditional Chinese medicine (TCM) (2nd ed). Stuttgart; New York: Thieme.

Kennedy, D. O. (2014). Plants and the human brain. New York: Oxford University Press.

Li, A., Tian, X., Sung, S.-W., & Somlo, S. (2003). Identification of two novel polycystic kidney disease-1-like genes in human and mouse genomes. Genomics, 81(6), 596–608.

Liu, M., Xu, Y.-F., Feng, Y., Yang, F.-Q., Luo, J., Zhai, W., … Zheng, J.-H. (2013). Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors. The Journal of Surgical Research, 183(1), 397–404.

Lu, P. H., & Hsu, C. H. (2016). Does supplementation with green tea extract improve acne in post-adolescent women? A randomized, double-blind, and placebo-controlled clinical trial. Complementary Therapies in Medicine, 25, 159–163.

McDonald, J. (2017). Foundational Herbcraft – Actions and Energetics in Traditional Western Herbalism.

Melhem, A., Stern, M., Shibolet, O., Israeli, E., Ackerman, Z., Pappo, O., … Ilan, Y. (2005). Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. Journal of Clinical Gastroenterology, 39(8), 737–742.

Mubarak, A., Bondonno, C. P., Liu, A. H., Considine, M. J., Rich, L., Mas, E., … Hodgson, J. M. (2012). Acute Effects of Chlorogenic Acid on Nitric Oxide Status, Endothelial Function, and Blood Pressure in Healthy Volunteers: A Randomized Trial. Journal of Agricultural and Food Chemistry, 60(36), 9130–9136.

Ochiai, R., Sugiura, Y., Otsuka, K., Katsuragi, Y., & Hashiguchi, T. (2015). Coffee bean polyphenols ameliorate postprandial endothelial dysfunction in healthy male adults. International Journal of Food Sciences and Nutrition, 66(3), 350–354.

Panossian, A., & Wikman, G. (2008). Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. Journal of Ethnopharmacology, 118(2), 183–212.

Santos, M. D. dos, Almeida, M. C., Lopes, N. P., & Souza, G. E. P. de. (2006). Evaluation of the Anti-inflammatory, Analgesic and Antipyretic Activities of the Natural Polyphenol Chlorogenic Acid. Biological and Pharmaceutical Bulletin, 29(11), 2236–2240.

Schöbel, N., Radtke, D., Kyereme, J., Wollmann, N., Cichy, A., Obst, K., … Hatt, H. (2014). Astringency Is a Trigeminal Sensation That Involves the Activation of G Protein–Coupled Signaling by Phenolic Compounds. Chemical Senses, 39(6), 1–1.

Shi, H., Dong, L., Jiang, J., Zhao, J., Zhao, G., Dang, X., … Jia, M. (2013). Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology, 303, 107–114.

Sinisi, V., Stevaert, A., Berti, F., Forzato, C., Benedetti, F., Navarini, L., … Vermeire, K. (2017). Chlorogenic Compounds from Coffee Beans Exert Activity against Respiratory Viruses. Planta Medica, 83(7), 615–623.

Skenderi, G. (2003). Herbal vade mecum: 800 herbs, spices, essential oils, lipids, etc., constituents, properties, uses, and caution. Rutherford, N.J: Herbacy Press.

Szopa, A., Ekiert, R., & Ekiert, H. (2017). Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies. Phytochemistry Reviews, 16(2), 195–218.

Tajik, N., Tajik, M., Mack, I., & Enck, P. (2017). The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature. European Journal of Nutrition.

Watanabe, T., Arai, Y., Mitsui, Y., Kusaura, T., Okawa, W., Kajihara, Y., & Saito, I. (2006). The Blood Pressure-Lowering Effect and Safety of Chlorogenic Acid from Green Coffee Bean Extract in Essential Hypertension. Clinical and Experimental Hypertension, 28(5), 439–449.

Yang, J., IP, S. P., J. Yeung, H., & Che, C. (2011). HPLC-MS analysis of Schisandra lignans and their metabolites in Caco-2 cell monolayer and rat everted gut sac models and in rat plasma. Acta Pharmaceutica Sinica B, 1(1), 46–55.

Ye, W., Chang, R. B., Bushman, J. D., Tu, Y.-H., Mulhall, E. M., Wilson, C. E., … Liman, E. R. (2016). The K+ channel KIR2.1 functions in tandem with proton influx to mediate sour taste transduction. Proceedings of the National Academy of Sciences, 113(2), E229–E238.

Yun, N., Kang, J.-W., & Lee, S.-M. (2012). Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. The Journal of Nutritional Biochemistry, 23(10), 1249–1255.

Zhao, M., Zheng, R., Jiang, J., Dickinson, D., Fu, B., Chu, T.-C., … Hsu, S. (2015). Topical lipophilic epigallocatechin-3-gallate on herpes labialis: a phase II clinical trial of AverTeaX formula. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 120(6), 717–724.

Research Summary: Plant based interventions for drug resistant infections.

Growing antimicrobial drug resistance is a significant global health problem (Weber, 2005).   There is a need for both novel antimicrobial interventions as well as methods for preserving the efficacy of existing interventions to address this issue.  Clinically, this rise in bacterial resistance has prompted recommendations that allopathic doctors prescribe fewer antibiotics. This in turn, has led to a search for alternatives (MacKay, 2003).  Research using current drug discovery technologies has provided evidence to support the traditional claims for many plant based interventions (Graziose, Lila, & Raskin, 2010).   Garlic (Allium sativum L.) has been used in traditional medicine to treat infections for millennia (Koch & Lawson, 1996).

A recent literature search of controlled clinical trials provided scant and conflicting results on garlic’s efficacy as an antimicrobial. Some trials provide preliminary evidence that garlic is effective against salivary Streptococcus mutans (Chavan, Shetty, & Kanuri, 2010) and chronic oral candidiasis (Bakhshi, Taheri, Basir Shabestari, Tanik, & Pahlevan, 2012).  Yet, an earlier systematic review of controlled clinical trials found that garlic provided no significant effect against Helicobacter Pylori (Martin & Ernst, 2003).   Furthermore, no human trials looking for a synergistic effect between garlic and the existing complement of pharmaceutical antibiotics were found in the literature.  This gap in the literature was unexpected primarily due to an increasing body of basic science on the efficacy of garlic as an antimicrobial both independently and in synergy with existing antimicrobial interventions.

In disk diffusion tests of Candida albicans, the antimicrobials fluconazole and itraconazole combined with Fresh Garlic Extract (FGE) showed greater inhibition zones against multi drug resistant C. albicans than the drugs alone (P<0.01) (Li et al., 2015).   Disk diffusion tests with methicillin-resistant Staphylococcus aureus and the drugs cefoxitin, oxacillin, and piperacillin showed larger inhibition zones (P <0.01) but the factorial analysis showed no positive interaction effects (P>0.05) (Li et al., 2015).   Applying the same test methodology to Pseudomonas aeruginosa resulted in a strong positive interaction between FGE and the anti-microbials cefotaxime & ceftriaxone (P < 0.01) (Li et al., 2015).   Despite larger inhibition zones, the anti-microbials levofloxacin, cefazolin and ampicillin did not show positive interaction effects with FGE on P. Aeruginosa (P>0.05) (Li et al., 2015).

An in-vitro disk/well diffusion study focused on Staphylococcus aureus isolates resistant to ampicillin with a mean minimum inhibitory concentration (MIC) of 24 μg/ml.  In all samples S. aureus showed statistically significant dose dependent increase in the zone of inhibition at FGE concentration 12.5 mg/ml and higher compared with the control (P>0.05).  The addition of 30-60 mg/ml of FGE reduced the MIC of ampicillin to 0.6-1.2 μg/ml (Pillai, Trivedi, & Bhatt, 2013).   Other well diffusion tests with the species Escherichia coli, Klebsiellosis pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Staphylococcus aureus all showed dose-dependent increases (P <0.05) in the zone of inhibition at FGJ concentration of 10% and higher compared to control (Yadav, Trivedi, & Bhatt, 2015).

Based on the increasing body of evidence for garlic’s bactericidal effects, a call for further research is justified.  Research is needed that more fully explores the phytochemical mechanisms that contribute to the possible synergistic effects of garlic with our existing antimicrobial arsenal.  Further clinical trial research is also needed to discover if there are replicable and generalizable garlic interventions that could be relevant to current clinical practice.



Bakhshi, M., Taheri, J.-B., Basir Shabestari, S., Tanik, A., & Pahlevan, R. (2012). Comparison of therapeutic effect of aqueous extract of garlic and nystatin mouthwash in denture stomatitis. Gerodontology, 29(2), e680–e684.

Chavan, S. D., Shetty, N. L., & Kanuri, M. (2010). Comparative evaluation of garlic extract mouthwash and chlorhexidine mouthwash on salivary Streptococcus mutans count – an in vitro study. Oral Health & Preventive Dentistry, 8(4), 369–374.

Graziose, R., Lila, M. A., & Raskin, I. (2010). Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Current Drug Discovery Technologies, 7(1), 2–12.

Koch, H. P., & Lawson, L. D. (1996). Garlic: the science and therapeutic application of Allium sativum L. and related species (2nd ed). Baltimore: Williams & Wilkins.

MacKay, D. (2003). Can CAM therapies help reduce antibiotic resistance? Alternative Medicine Review: A Journal of Clinical Therapeutic, 8(1), 28–42.

Martin, K. W., & Ernst, E. (2003). Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. Journal of Antimicrobial Chemotherapy, 51(2), 241–246.

Pillai, R., Trivedi, N. A., & Bhatt, J. D. (2013). Studies on in vitro interaction of ampicillin and fresh garlic extract against Staphylococcus aureus by checkerboard method. Ancient Science of Life, 33(2), 114–118.

Li, G., Ma, X., Deng, L., Zhao, X., Wei, Y., Gao, Z., … Sun, C. (2015). Fresh Garlic Extract Enhances the Antimicrobial Activities of Antibiotics on Resistant Strains in Vitro. Jundishapur Journal of Microbiology, 8(5).

Yadav, S., Trivedi, N. A., & Bhatt, J. D. (2015). Antimicrobial activity of fresh garlic juice: An in vitro study. AYU: An International Quarterly Journal of Research in Ayurveda, 36(2), 203–207.

Weber, C. J. (2005). Update on Antimicrobial Resistance. Urologic Nursing, 25(1), 55–57.

Witch Hazel Dosing Overview.

Hamamelis Virginiana has an interesting range of doses.  It also excels as a simple.   This research I conducted as part of the HRB 600 coursework at MUIH is an attempt to recognize and articulate complex and multidisciplinary questions and ideas around how to utilize herbal medicine in health and wellness practices.  One of the questions central to the practice of herbal medicine is the question of dosing.  Witch hazel is an interesting plant to discuss because it’s common usage in modern culture is as a distillate which does not contain many of the constituents that made it a popular remedy in the 19th centrury.

Witch Hazel.

Thomson was a big proponent of witch hazel.

Thompson sums up one extreme end of the spectrum by stating, “A tea made of the leaves, is an excellent medicine in many complaints, and may be freely used to advantage” (Thompson, 1825).

Felter advises a dosage of specific medicine Hamamelis should contain 5 to 60 minims or drops (Felter, 1922) which in modern terms is ~0.3ml. – 3.7ml. Notably he does not specify which solvent to use to make the specific medicine.  Michael Moore’s introduction to the SWBS release of Felter’s opus points out that “You cannot translate a Specific Medicine into “tincture” or “fluidextract”. The latter are generic or standard strengths applied across the board to ALL botanicals. A Specific Medicine represented the greatest strength, without degradation, for a particular plant, using anywhere from several to all of the solvents to achieve this” (Moore, 2001).

Continue reading

Herbcalc 0.1 Beta.

Herbcalc 0.1 is released for beta testing.

Herbcalc came out of my experiences in HRB622 at MUIH.  It is at it’s essence an attempt to demonstrate my application of rational understanding of extraction protocols, including properties of common solvents (e.g. water, alcohol and oils) and the solubility of various herbal constituents to produce quality herbal preparations.

Please access it here

Its intended to ultimately be a convenient way to conduct the important calculations for ethanolic percolation and maceration as well as oil infusions.

A picture of samuel thomson

Samuel Thomson could have used Herbcalc.

As development progresses, there will be error checking for common errors along with a list of likely constituent profiles based on chosen menstruum.

Additionally a list of references for traditionally  popular and frequently used ratios will be available for commonly used species (example: echinacea)

Finally by the 1.0 release there will be an option to print out a form for inclusion in a medicine making journal that will have the core elements needed to facilitate cGMP compliance for those herbalists concerned with that or rich and detailed journal entries for D.I.Y. practitioners.

The folk method is a noble and storied tradition with a legitimate place in phytotherapeutics, but Herbcalc will serve as a useful tool for those who desire consistency in production,  and a clearer understanding of what the constituent profile is of an extraction they are conducting.

Herbcalc is inspired by the remarkably useful Soapcalc which serves as an invaluable resource to home artisan soap makers.


Eyebright and the Ethics of Wildcrafting.


Eyebright: at risk.

This paper was a result of my work in HRB 622.  But I think it reinforces and demonstrates the learning I acquired in HRB605.  I feel that this paper indicates one method of how to apply traditional knowledge and evidence based data by assessing a variety of plant classification systems, including phytochemistry, botanical, cultural and bioregional, to improve human health.  The comparison of constituents found in eyebright and plantain provides a convincing case for how phytochemistry and evidence based data can inform and build on the traditional body of knowledge that comprises western herbalism.


Eyebright and the Ethics of Wildcrafting.

Plantago Major

The Noble Plantain

Wildcrafting is an important component of traditional herbal medicine. Many herbalists would argue that wildcrafting and encountering species in their native habitats is a necessary component in developing a competent and meaningful relationship with with those plants. There is also an argument that as a result of complex mechanisms such as hormesis cultivated plant specimens have the potential of containing a subtly different, and often weaker, constituent profile. Other herbalists will argue that these differences between wild and cultivated plants are negligible in a therapeutic context and the solution to over-harvesting of wild therapeutics is to use only cultivated varieties.

Continue reading